Myeloproliferative Neoplasm Stocks List
Related Industries: Biotechnology
Related ETFs - A few ETFs which own one or more of the above listed Myeloproliferative Neoplasm stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PBE | D | PowerShares Dynamic Biotech & Genome | 2.68 | |
WDNA | D | WisdomTree BioRevolution Fund | 2.29 | |
BBP | D | BioShares Biotechnology Products Fund | 2.14 | |
HAPS | D | Harbor Corporate Culture Small Cap ETF | 1.99 | |
LABD | B | Direxion Daily S&P Biotech Bear 3X Shares | 1.61 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Apr 18 | BPMC | Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024 |
- Myeloproliferative Neoplasm
The myeloproliferative neoplasms (MPNs), previously myeloproliferative diseases (MPDs), are a group of diseases of the bone marrow in which excess cells are produced. They are related to, and may evolve into, myelodysplastic syndrome and acute myeloid leukemia, although the myeloproliferative diseases on the whole have a much better prognosis than these conditions. The concept of myeloproliferative disease was first proposed in 1951 by the hematologist William Dameshek. In the most recent World Health Organization classification of hematologic malignancies, this group of diseases was renamed from "myeloproliferative diseases" to "myeloproliferative neoplasms". This reflects the underlying clonal genetic changes that are a salient feature of this group of disease.
The increased numbers of blood cells may not cause any symptoms, but a number of medical problems or symptoms may occur. The risk of thrombosis is increased in some types of MPN.
Popular Now
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles